Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07125001 · ClinicalTrials.gov registry record · NA
Mango Intake and Gut and Cardiometabolic Health in Hispanic/Latino Adolescents
A NA study of Inflammation and Cardiometabolic Health Indicators, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07125001: Recruiting NA study of Inflammation and Cardiometabolic Health Indicators, sponsored by University of California, Davis.
NCT07125001 is a NA study of Inflammation and Cardiometabolic Health Indicators that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 25 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07125001, a NA study of Inflammation and Cardiometabolic Health Indicators, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Mangos contain a number of nutrients that may improve gut and metabolic health. The purpose of this research is to see how eating mangos every day for 4 weeks instead of snacks high in calories and low in nutrients such as cookies, crackers, chips, and candy can impact adolescent health.
Primary Outcome
Microvascular function as measured by peripheral arterial tonometry (ENDO PAT 2000)
Conditions Studied
Interventions
- OTHER Ataulfo mango
Study Locations (1)
California
- Academic Surge; Ragle Human Nutrition Research Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT07125001 shows while recruiting
NCT07125001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Ataulfo mango is the first listed.
NCT07125001 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07125001 about?
NCT07125001 is a clinical study titled "Mango Intake and Gut and Cardiometabolic Health in Hispanic/Latino Adolescents". Mangos contain a number of nutrients that may improve gut and metabolic health. The purpose of this research is to see how eating mangos every day for 4 weeks instead of snacks high in calories and low in nutrients such as cookies, crackers, chips, and candy can impact adolescent health.
What is the current status of trial NCT07125001?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-10-01. Estimated completion is 2028-03-31.
What conditions does trial NCT07125001 study?
This clinical trial studies the following conditions: Inflammation, Cardiometabolic Health Indicators, Vascular Function in Healthy Volunteers.
What interventions are being tested in trial NCT07125001?
The interventions under investigation include: Ataulfo mango (OTHER).
Who is sponsoring clinical trial NCT07125001?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07125001 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07125001's enrollment target sits among peer trials
25 113th of 132 higher than 17 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI